Tabula Rasa Ventures

Tabula Rasa Ventures operates as a specialized financial investment firm, strategically backing the next generation of health innovation. The firm focuses on early-stage healthcare startups, deploying capital into ventures centered on drug development and enhancing patient access. Their investment thesis embraces a holistic, preventative, personalized, and democratized approach to human health, notably including opportunities within the burgeoning psychedelics space.

Marik Hazan co-founded Tabula Rasa Ventures in 2019, establishing the firm with an insight into a shifting healthcare paradigm. The firm's foundation reflects a commitment to supporting founders and researchers who are challenging conventional healthcare models. Hazan’s vision for a “blank slate” approach underpins the firm’s strategy, aiming to maximize returns by identifying and nurturing disruptive health solutions.

The firm's clientele primarily comprises innovative healthcare startups and pioneering researchers, seeking capital and strategic partnership to bring novel solutions to market. Tabula Rasa Ventures envisions a future where health is fundamentally reimagined, actively building a portfolio that drives advancements towards a more accessible, personalized, and proactive health ecosystem for all.